Cyclic Di-GMP Riboswitch-Regulated Type IV Pili Contribute to Aggregation of Clostridium difficile
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Clostridium difficile is an anaerobic Gram-positive bacterium that causes intestinal infections with symptoms ranging from mild diarrhea to fulminant colitis. Cyclic diguanosine monophosphate (c-di-GMP) is a bacterial second messenger that typically regulates the switch from motile, free-living to sessile and multicellular behaviors in Gram-negative bacteria. Increased intracellular c-di-GMP concentration in C. difficile was recently shown to reduce flagellar motility and to increase cell aggregation. In this work, we investigated the role of the primary type IV pilus (T4P) locus in c-di-GMP-dependent cell aggregation. Inactivation of two T4P genes, pilA1 (CD3513) and pilB1 (CD3512), abolished pilus formation and significantly reduced cell aggregation under high c-di-GMP conditions. pilA1 is preceded by a putative c-di-GMP riboswitch, predicted to be transcriptionally active upon c-di-GMP binding. Consistent with our prediction, high intracellular c-di-GMP concentration increased transcript levels of T4P genes. In addition, single-round in vitro transcription assays confirmed that transcription downstream of the predicted transcription terminator was dose dependent and specific to c-di-GMP binding to the riboswitch aptamer. These results support a model in which T4P gene transcription is upregulated by c-di-GMP as a result of its binding to an upstream transcriptionally activating riboswitch, promoting cell aggregation in C. difficile .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hellemans, J., Mortier, G., De Paepe, A., Speleman, F., & Vandesompele, J. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r19 · Cited by 4,023
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380 · cited 1×
“The Gram-positive spore-forming bacterium Clostridium difficile is the leading cause of nosocomial diarrhea and antibioticassociated colitis in hospital settings (1).”
BackgroundLawley, T. D., Clare, S., Walker, A. W., Goulding, D., Stabler, R. A., Croucher, N., Mastroeni, P., Scott, P., Raisen, C., Mottram, L., et al. (2009) · Infection and Immunity · doi:10.1128/iai.00558-09 · Cited by 349 · cited 1×
“difficile cells, described as cell aggregates, were observed in a mouse model of colonization and suggest that aggregation and/or biofilm could be important for colonization (85).”
BackgroundPurdy, D., O'Keeffe, T. A. T., Elmore, M., Herbert, M., McLeod, A., Bokori‐Brown, M., Ostrowski, A., & Minton, N. P. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03134.x · Cited by 255
Group II introns as controllable gene targeting vectors for genetic manipulation of bacteria
Karberg, M., Guo, H., Zhong, J., Coon, R., Perutka, J., & Lambowitz, A. M. (2001) · Nature Biotechnology · doi:10.1038/nbt1201-1162 · Cited by 222 · cited 1×
“The pilA1 and pilB1 genes were insertionally inactivated using a group II intron retargeting approach (44) adapted for Clostridium, the ClosTron, as previously described (45).”
MethodSaujet, L., Monot, M., Dupuy, B., Soutourina, O., & Martin-Verstraete, I. (2011) · Journal of Bacteriology · doi:10.1128/jb.00272-11 · Cited by 173
Hensbergen, P. J., Klychnikov, O. I., Bakker, D., van Winden, V. J. C., Ras, N., Kemp, A. C., Cordfunke, R. A., Dragan, I., Deelder, A. M., Kuijper, E. J., et al. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.034728 · Cited by 68
Cited by
Cyclic di-GMP: second messenger extraordinaire
Jenal, U., Reinders, A., & Lori, C. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.190 · Cited by 1,039
Clostridium difficile colitis: pathogenesis and host defence
Abt, M. C., McKenney, P. T., & Pamer, E. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.108 · Cited by 551
Zhao, Z., Li, Y., Quan, X., & Zhang, Y. (2017) · Water Research · doi:10.1016/j.watres.2017.02.067 · Cited by 343
Yin, Q., & Wu, G. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107443 · Cited by 189
Bervoets, I., & Charlier, D. (2019) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuz001 · Cited by 180
Liang, Y., Ma, A., & Zhuang, G. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.829717 · Cited by 146
Hensbergen, P. J., Klychnikov, O. I., Bakker, D., Dragan, I., Kelly, M. L., Minton, N. P., Corver, J., Kuijper, E. J., Drijfhout, J. W., & van Leeuwen, H. C. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.027 · Cited by 54
Corver, J., Cordo’, V., van Leeuwen, H. C., Klychnikov, O. I., & Hensbergen, P. J. (2017) · Molecular Microbiology · doi:10.1111/mmi.13736 · Cited by 20
“In addition to these effects, flagellar genes (c-diGMP type I riboswitch) and the type IV pilus locus (c-diGMP type II riboswitch) probably also play a role (Purcell et al., 2012; Bordeleau et al., 2015).”
BackgroundMolecular and Functional Analysis of the Type IV Pilus Gene Cluster in Streptococcus sanguinis SK36
Chen, Y.-Y. M., Chiang, Y.-C., Tseng, T.-Y., Wu, H.-Y., Chen, Y.-Y., Wu, C.-H., & Chiu, C.-H. (2019) · Applied and Environmental Microbiology · doi:10.1128/aem.02788-18 · Cited by 13
“For instance, pilA1 of Clostridium difficile is preceded by a c-di-GMP transcriptional riboswitch, and the transcription of pilA1 is upregulated by c-di-GMP (15).”
Background
Metadata
- Authors
- Bordeleau, E., Purcell, E. B., Lafontaine, D. A., Fortier, L.-C., Tamayo, R., & Burrus, V.
- Venue
- Journal of Bacteriology
- Publisher
- American Society for Microbiology
- Published
- 2015-03
- Volume
- 197
- Issue
- 5
- Pages
- 819-832
- ISSN
- 0021-9193 (ISSN-L)
- 1098-5530
- OpenAlex
- W2171757585
- Cited by
- 143
- References
- 7
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.